Repare Therapeutics Inc (RPTX) 20 Days SMA touches 23.12%: The odds favor the bear

Repare Therapeutics Inc (NASDAQ: RPTX) on Monday, soared 8.80% from the previous trading day, before settling in for the closing price of $7.73. Within the past 52 weeks, RPTX’s price has moved between $3.08 and $13.85.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Healthcare Sector giant saw their annual sales surged by 1791.06% over the last five years. The company achieved an average annual earnings per share of -196.61%. With a float of $31.80 million, this company’s outstanding shares have now reached $42.04 million.

Repare Therapeutics Inc (RPTX) Insider Activity

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Repare Therapeutics Inc is 24.51%, while institutional ownership is 67.91%. The most recent insider transaction that took place on Nov 16, was worth 1,592,202. In this transaction 10% Owner of this company bought 295,745 shares at a rate of $5.38, taking the stock ownership to the 5,309,432 shares. Before that another transaction happened on Nov 15, when Company’s 10% Owner bought 931,556 for $5.00, making the entire transaction worth $4,657,687. This insider now owns 5,155,739 shares in total.

Repare Therapeutics Inc (RPTX) Earnings and Forecasts

As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.45 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.86) by $0.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -196.61% per share during the next fiscal year.

Repare Therapeutics Inc (NASDAQ: RPTX) Trading Performance Indicators

Repare Therapeutics Inc (RPTX) is currently performing well based on its current performance indicators. A quick ratio of 5.62 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.30.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.32, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -3.13 in one year’s time.

Technical Analysis of Repare Therapeutics Inc (RPTX)

Analysing the last 5-days average volume posted by the [Repare Therapeutics Inc, RPTX], we can find that recorded value of 0.25 million was better than the volume posted last year of 0.2 million. As of the previous 9 days, the stock’s Stochastic %D was 81.47%. Additionally, its Average True Range was 0.61.

During the past 100 days, Repare Therapeutics Inc’s (RPTX) raw stochastic average was set at 49.49%, which indicates a significant decrease from 96.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.92% in the past 14 days, which was lower than the 99.56% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.72, while its 200-day Moving Average is $8.44. Now, the first resistance to watch is $8.69. This is followed by the second major resistance level at $8.97. The third major resistance level sits at $9.45. If the price goes on to break the first support level at $7.93, it is likely to go to the next support level at $7.45. Should the price break the second support level, the third support level stands at $7.17.

Repare Therapeutics Inc (NASDAQ: RPTX) Key Stats

Market capitalization of the company is 354.31 million based on 42,130K outstanding shares. Right now, sales total 131,830 K and income totals -29,050 K. The company made 2,160 K in profit during its latest quarter, and -18,880 K in sales during its previous quarter.